<SEC-DOCUMENT>0000849146-14-000053.txt : 20140805
<SEC-HEADER>0000849146-14-000053.hdr.sgml : 20140805
<ACCEPTANCE-DATETIME>20140805091743
ACCESSION NUMBER:		0000849146-14-000053
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140805
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140805
DATE AS OF CHANGE:		20140805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		141014793

	BUSINESS ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kprelimearningsreport.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>8-K:  Prelim. Earnings Report</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s32D86BA17FD4D24A1197A3543DCB44C8"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): August 5, 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;text-align:center;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="32%"></td><td width="6%"></td><td width="28%"></td><td width="6%"></td><td width="28%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Colorado</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9785 S. Monroe Street, Suite 300, Sandy, UT 84070</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices and Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801)&#160;432-9000</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="70px"></td><td width="612px"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s171a9aeddf924534bced5f476189762c"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12%"></td><td width="88%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;2.02</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations and Financial Condition.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2014, LifeVantage Corporation (the &#8220;Company&#8221;) issued a press release announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2014.  A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s3c14d5747cb7477ab0ac3c7d56db65f9"></a><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12%"></td><td width="88%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;Exhibits</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="12%"></td><td width="1%"></td><td width="3%"></td><td width="3%"></td><td width="81%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release issued by the Company on August 5, 2014 announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="saa11b24c66f846d584de560dc7369f2f"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:682px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="341px"></td><td width="341px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: August 5, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By: </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Rob Cutler</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name: Rob Cutler</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: General Counsel</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>prelimrelease.htm
<DESCRIPTION>EXHIBIT
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>Prelim. Release</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sECDF7A4249B72FC541F8A3734F9988F2"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:138%;padding-bottom:4px;text-align:center;"><img src="lifevantagelogojpega03.jpg" style="font-family:Arial;font-size:12pt;font-weight:bold;height:41px;width:268px;"></div><div style="line-height:138%;padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">LIFEVANTAGE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL FISCAL 2014 RESULTS</font></div><div style="line-height:138%;padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Fourth Quarter Net Revenue Increased 8.8% Over Prior Year Period to $56M</font></div><div style="line-height:138%;padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Full Fiscal Year Net Revenue Increased 2.8% Over Fiscal 2013 to $214M</font></div><div style="line-height:138%;padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Company Reduced Debt by Approximately $15M During the Fourth Quarter of Fiscal 2014 </font></div><div style="line-height:138%;padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">SALT LAKE CITY, UT, August 5, 2014 (GLOBE NEWSWIRE) &#8212; LifeVantage Corporation (NASDAQ: LFVN) today announced preliminary financial results for the fourth quarter and the full fiscal year ended June 30, 2014.  </font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">The Company expects fourth quarter revenue of approximately $56 million, representing growth of 8.8% over the prior year period.  Revenue growth in the quarter was driven by new product introductions, as well as improvements in the North America, Hong Kong and Philippines markets. Revenue for fiscal 2014 is expected to be approximately $214M, or a 2.8% increase over the prior year.  Foreign currency fluctuation negatively impacted full year revenue by approximately $10.4 million, or 5%.  For the full fiscal year, the Company&#8217;s operating margin is expected to be approximately 9% and diluted earnings per share are expected to be approximately $0.10.    </font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">&#8220;During the past 9 months, we have implemented a number of strategies and improvements that are enabling our company to return to top line growth.  This growth is a direct result of new additions to our senior management team, as well as executing on product, geographic and sales related growth strategies.  We believe establishing and executing on our stated strategies has us well positioned for sustaining growth throughout fiscal 2015 and beyond,&#8221; stated Douglas C. Robinson, LifeVantage President and Chief Executive Officer.</font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">During the fourth quarter of fiscal 2014, the company reduced its overall debt to approximately $31 million from approximately $46 million.  The company ended fiscal 2014 with approximately $20 million in cash and cash equivalents.</font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">The Company expects to release its complete financial results for the fourth quarter and fiscal year ended June 30, 2014 and to provide guidance for fiscal 2015 in connection with its full earnings release and investor call scheduled to be held on September 10, 2014.</font></div><br><div></div><hr style="page-break-after:always"><a name="sECDF7A4249B72FC541F8A3734F9988F2"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:138%;padding-bottom:4px;padding-top:12px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">About LifeVantage Corporation</font></div><div style="line-height:138%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">LifeVantage Corporation (NASDAQ: LFVN), a leader in Nrf2 science and the maker of Protandim&#174;, the Nrf2 Synergizer&#174; patented dietary supplement, TrueScience</font><font style="font-family:Arial;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">TM</sup></font><font style="font-family:Arial;font-size:12pt;">&#32;Anti-Aging Skin Care Regimen and Canine Health, is a science-based network marketing company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and is headquartered in Salt Lake City, Utah.</font></div><div style="line-height:138%;padding-bottom:4px;padding-top:12px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:138%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism and satisfaction with current prospects, as well as words such as &#8220;believe,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to,&#8221; &#8220;should&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements about management&#8217;s expectations regarding the company&#8217;s performance, initiatives and strategies; statements of current estimates of the company&#8217;s revenue, earnings per share, foreign currency impact and other financial items; statements of management&#8217;s expectations and plans related to the timing of the release of the company&#8217;s full financial results for fiscal 2014 and guidance for fiscal 2015; statements of belief, and statements of assumptions underlying any of the foregoing.  Such forward-looking statements are not guarantees of performance and the Company&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company&#8217;s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the risk factors discussed in greater detail in the Company&#8217;s Annual Report on Form 10-K and its Quarterly Report on Form 10-Q under the caption &#8220;Risk Factors,&#8221; and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investor Relations Contact:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Cindy England (801) 432-9036 <br>Director of Investor Relations <br></font></div><br><div></div><hr style="page-break-after:always"><a name="sECDF7A4249B72FC541F8A3734F9988F2"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">-or- <br>John Mills (646) 277-1254</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Partner, ICR, INC</font></div><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lifevantagelogojpega03.jpg
<TEXT>
begin 644 lifevantagelogojpega03.jpg
M_]C_X``02D9)1@`!`0$`E@"6``#_X0!:17AI9@``34T`*@````@`!0,!``4`
M```!````2@,#``$````!`````%$0``$````!`0```%$1``0````!```7$5$2
M``0````!```7$0```````8:@``"QC__;`$,`"`8&!P8%"`<'!PD)"`H,%`T,
M"PL,&1(3#Q0=&A\>'1H<'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_;`$,!"0D)#`L,&`T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_``!$(`$\!]P,!(@`"$0$#$0'_
MQ``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#
M!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!
M`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<`
M`0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`
M$)`&2<`5E:Q<&;2KJ*UD83,AVE>/PS5G4'(1$'0\FL^MJ4=I'/6G=.!Q_A?7
M#I>JB&>1OLL_RL">%;L?Z&O0_M\/^U^5>>^)M#92]]:H6C/,J*/NGU'M5KPS
MX@2]C6QNI`+I!A&)_P!8/\:ZZ].-3]XCAPM2=']U+Y'<?;X?]K\J/M\/^U^5
M9E96MZW'HT"L8C+*_P!U,X&/4FN>-%2=D=<J[BKLZI+V%VQN(^HJQ7">'/%%
MOXA^T1+"T%S;XWQDY!!Z$&NRLG+VXSS@XJ*M+D-*5;G+-9-WXCTVRNGMIY76
M1/O`(3VS6M7FOB;_`)&*[^J_^@BM,)1C5FXR[&&/Q,\/34H=ST2TNHKVUCN(
M"3&XRI(Q4U97AO\`Y%ZS_P!T_P`S6K6%2*C-Q70ZJ4G.G&3ZI!1114&@445!
M>7"VEG-<,,B)"V/7`II-NR$VDKLBOM5LM-4&ZG5">B]6/X"H-.U^PU2=H;9G
M\Q5W89".*\ZDDN=2OB[;I;B9N!ZD]`/:NO\`#F@7NEZ@;BX\K:T17"MD@Y%=
M]7"TZ5/WG[QY-''5J]:T(^Z=31117GGKA1110`5FWWB#2-,NTM+[4;>WN'`*
MQRN%)!.!^M:5>=_%SP__`&CX>3584S<6!R^!R8CU_(X/YUI2C&<U&74RK3E"
MFY15['HE%<M\/_$'_"0^$[::1]UU;_N)_4LHX/XC!_.NIJ9Q<).+Z%PFIQ4E
MU"BBBI*&R2)#$\LKA(T4LS,<``=2:I:;K>EZSYG]FWT%UY6-_E-NVYZ9_(UQ
MWQ:\0?V7X:&FPOBXU`E#CJ(Q][\^!^)K5^'GA_\`X1_PG;QR)MNKG]_/QR"1
MP/P&!]<UM[)*ESOKL8>U;K>SCLEJ=71116)N%%%%`!1110`4444`%%%%`!7(
M>._&<O@^"RDBLDNOM+LI#2%=N`/8^M=?7E/QM_X\]&_ZZR_R6M\-!3JJ,MCG
MQ4Y0HN4=SU.&3S8(Y",;U#8],BGU!9_\>-O_`-<U_E4]8O<W6P4444AA1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%#4>L?XU1J]J/6/\`
M&LRYN8+.V>XN95BA099V/`KII_"CDJ_$R6N:UGP?;7K&>SE%G<DY']PG^A^E
M<EXD^(MY*6@T<&VASCSF&9&^G]W^=<K#I?B/4;B.]DM-2G0.&:616(QG.<FN
MRG1DM6['!5Q$;\J5ST0ZWXJ\/1[=3TEM1MD_Y>(&RP'N1U_$"KC>1XWT>.\L
MRUM-&QC:*<<J?0X_,'WJ/PSXC?4KJ;1+S<\HB+1R_P!Y>A!]QGK6MX?S']J@
M;[R.,_J/Z4G[J;M9HI6G97NF5?"WA4>'Y+JYEG6:YN,*=@(55'8>M=O8?\>Y
M_P!ZLRM.P_X]S_O5R5I.2NSMH1479%JO-?$W_(Q7?U7_`-!%>E5YKXF_Y&*[
M^J_^@BMLO_BOT.7-_P""O7]&=KX;_P"1>L_]T_S-:M97AO\`Y%ZS_P!T_P`S
M6K7)6_B2]6=^'_@P]%^05A>+G>/0F9'9&\Q>5.#UK=JIJ-[;:?:&>ZSY08#A
M<\GVHI-JHFE<,1%2I23=M-SC_!T\TFLNKS2./))PS$]Q6YXHU.WMM/ELI-_G
M7$9V87CKW-6M-UO3M1N3#:;O,"ECF/;Q61XQTZYN#'=QHIA@C/F$M@CGTKLN
MJF)3FN4\_E=+!R5*7-_6IS.CW<5CJUO<S`^7&23@9/0BN_TS7;/5I7BMO,W(
MNX[TQQ7G%K:RWMREO``9'.%!.*[+POHM]IEY/)=1JJO&%&'!YS6^-A3:YF_>
MZ')EE2LI*$5[K>NGD=16#J/BRPLG:*+=<RC@B,_*/Q_PK-\6ZXZN=-MG*\?O
MF!YY_A_QK%T?0+G5R74B*W4X,C#K[`=ZYZ.%@H>TK.R.O$XZHZGL<.KLU&\<
M7.[Y;*(+Z%SFKUEXTM96"7<#P9_C!W+_`(T]?!.G!,/-<LW]X,!^F*QM7\)S
MV$37%JYN(5&6!&&4>OO6B6#J/E6AC)YA27.]5\CNXI4FC62)U=&&593D&DG@
MCN;>2"9`\4JE'4]"",$5Y]X<UM],NUAD<FTE;#`G[A/\0_K7HM<>(H2HRL>E
MA,5'$POUZH\7\&SR>"?B1=^'KIR+6Z?RD+=">L;?B#C\:]HKRWXP:$YMK3Q#
M:@K-:L(IF7J%)RK?@W'XUW'A/7$\1>&K/401YCIMF`_AD'#?KS]"*TK_`+R$
M:J]'ZD8;]W.5%]-5Z&U1G`R:*X[XE>(/["\)S+$^VZO/W$6.H!'S-^`_4BN:
M$'.2BNIU5)J$7)]#A8,_$/XKM*?GTRR.1Z&-#Q_WTW/T->UUPGPJ\/\`]D>%
MEO)4Q<Z@1*<CD1_P#\LG\:I_$SQA<Z?Y7A_1V?\`M&[`\QH_O(IX"K_M-^@^
MM=55>UJJG#9:')1DJ-%U:F[U_P`D;'B/XCZ%X=E>W:1KN\7AH;?!VG_:;H/Y
MUR1^,&JW!+V?AHO".^]VX^H7%;G@_P"&6GZ1;QW>KQ)>ZDPW,L@W1Q'T`Z$^
MY_"N_5510J*%4<``8`J7*A#1+F\RE'$5-7+E\CS'3/C-82S"'5M-GLSG!>-O
M,`^HP"/UKH]%^(&EZ]XCDT>QBF<HK.MQQY;@8Y'.>_I6KK?AC2/$-NT6HV4<
MC$?+*!B1?HW6O*_`.FIHWQ8O=-CD:1+:.:-788)`(ZU:C1J0E**LTB)2KTIQ
MC)W39[6>!FN*TOXGZ#?PWLUP9+&.T*@FX(RY.>%`))/%=HWW3]*\!^'WA"U\
M4Z[>/?L3:69#-$IP9"Q.!GL.#FLZ%.$H2E/I8TQ%6I"<(T^MSL[KXQV;3&+2
M=&O+UAT).S/X`$U7_P"%LZM!^\N_"-S'#W;<XQ^:8KTJQTZRTRW6"QM(;>(#
M`6)`HJU2]I16T/Q'[*N]74_!''^'/B1H/B*9+99'M+Q^%AN,#<?16'!^G6NP
MKSSXB>!;"_T>YU>PMTM]0MD,S&(;1*HY(('?'(-:?PUU^?7_``G&]VY>YMG,
M$CGJ^`""??!'Y45*<'#VE/;J@IU9JI[*IOT?<9XH^(VG>%=6&G75G=2R&(2;
MHMN,'/J?:O,_'_CFQ\7P6,=G:W$)MG=F,NWG('3!/I7NEQIFGW<OFW-C;3R8
MQOEA5CCZD5Y9\8]/LK*TT@VEG;P%I)-QBB"YX7K@5MA94^>*2U,,9&K[.3<M
M.UB]!\9]&BMXXSIU\2B!3]SL/K7;^&/$=MXITC^T;6&6*/S&CVRXSD?0^]/M
M-#TAK.`G2K$DQJ23;IZ?2J7B;6['P7X;ENH;:%&+;8((U"!Y#[#MQD_2L9>S
MF^6G'7U.B'M*:YJDM/0MZ_XHTCPU;B74[H1LP^2)1ND?Z+_7I7`3_&62>8II
M6@2SJ#UDD.3_`,!4''YU4\'^";CQ?<-XE\42R31SMNBA)P91ZGT3T`_EU];M
M+*UL(%@L[:*WB48"1(%'Z5<E1I>ZUS/\#.+KUO>3Y5^)Y=!\998)@FJ^'Y85
M)ZI(0P_!@,_G6W<?%KP_&MH;9+BY-P<%54*T1R!A@3[]LUVMY8VFH6[07EM%
M<0L,%)4##]:\.^('A2P\,^(M.;3MZ0W;[O)8Y$9##H>N.>]725"K*W+9D5GB
M*,>;FNO0]YHH[5YU\2_&-QIB1:#I#-_:5V!O:/[T:DX`7_:8_E^5<E.FZDN5
M'95JQI0<I&QXD^(NA>')'MY)6NKQ>#!;X)4_[1Z#^?M7(_\`"X-3N"7L_#+/
M#V.]F_4+BMKP=\,;#28([S68DO-28;BLGS1Q'T`_B/N?PKT!45%"HH51P`!@
M"MW*A#1+F\SG4<14]YRY?(\QTSXS6,DXAU;3)[,YP7C;S`OU&`1^M=%H_P`0
M=+USQ*^C6,<TA"LRW`QY;@`'CG/?TK7UKPUI'B"W:'4;*.4D<2`8=?<-U%>4
M^!]+31?B[<Z;'(TD=LDJ*[#DC`ZU<8T:D9.*LTB)2KTIQC)W39[93))8X8FE
ME=4C099F.`!ZDT^O'/$NJZC\0O%?_"-:-*4TV!CYT@^ZVT_,[>H!X`[G].>E
M2=1]DMSIK5E36UV]D;^M?%_1;"9H-.@EU&0'&]#LCS[$\G\!6/\`\+>UA1YK
M^&&$/KN<<?7;BN[\.^"M%\-P*+6U22X`^>YE`:1C]>WT%=#6KJ4(Z*-_5F2I
MXB6LIV\DC@]!^*^A:O*MO=A].G8X'G$&,G_>'3\<5W8(8`@@@\@BN3\4?#[1
MO$=O(ZP):7V/DN(EQD_[0'WA^M<EX"\1:CX>\0-X.UXG`;9;.QSL;J%![JPZ
M?_7H=.%2+E2W704:M2G)0JZI[/\`S/6J***Y3L"BB@G`R>E`&5K=S#9V_P!H
MN'"11J2S'_/6O*;^XU/QGJHM[9"L"'*H3\L8_O,?7_(K;\1ZC<>+-;33;`YM
M(6.&['U<^WI_]>NAL[2R\/Z<(D#+&.9)-A)8^IQ7H4X^SBNYYM62J2=G[I2T
M/PAIFBA9?*6YO.\\JYP?]D=OYULWA_T*X)/2)OY4EM>6UXI:VN(Y0.NULD?A
M1>_\>%S_`-<F_E4W;EJ.T5'W3S?P;_R/1_Z])/YK7=D?8]>5^D=TNT_[P_S^
MM<)X-_Y'H_\`7K)_-:]&OK47=L8P=L@.Y&]&'2MJKM/7L84%>GIW+-:=A_Q[
MG_>K)A,C0H9E"R$?,`<\UK6'_'N?]ZN.KL=U'XBU7FOB;_D8KOZK_P"@BO2J
M\U\3?\C%=_5?_016^7_Q7Z')F_\`!7K^C.U\-_\`(O6?^Z?YFM6LKPW_`,B]
M9_[I_F:U:Y*W\27JSOP_\&'HOR"L#QA_R`&_ZZ)_.M^L#QA_R`&_ZZ)_.JP_
M\6/J1C/]WGZ,P/!?_(:D_P"N)_F*ZOQ#_P`B_>_]<S7*>"_^0U)_UQ/\Q75^
M(?\`D7[W_KF:ZL5_O*^1PX+_`'*7S_(X?PW_`,C#9_[Q_D:]*8A5+'H!DUYK
MX;_Y&&S_`-X_R->E,NY&4]QBEF'\1>@\H_@R]?T1Y+<3&YNY)I"<R.68_4UV
M=MXLT>TMH[>**Y6.-=H'EC_&N+EB,-P\4@(*.5;UX-=;#X+M9X4ECU"1D=0R
MD(.0:[,2J/*O:/0\[!/$<TG12;ZW+G_"::9_SSN?^^!_C1_PFFE_\\[G_OV/
M\:K?\(-!_P`_TO\`WP*/^$&@_P"?Z7_O@5R<N#[L]#FS'LOP_P`SE+][:2^F
M>T5E@=MRJPP1GM7H^A7#76B6DK'+&/:3[CC^E8?_``@T'_/]+_WP*Z'3;%=-
MT^*T5RXCS\Q&"<DG^M&+K4JE-1@[M!@,-7I592J*R8NI6$&JZ9<V%RN8;B,Q
MM^(Z_45Y/\,K^?P]XKU#PK?MM\QV\O/3S%]/]Y>?P%>Q5Y%\5]*FTO6=/\56
M&4D#JDC#M(O*$_4`C\!6.&:E>D^OYG7BDXVK+[/Y'KM>*^(';Q]\4H-)B8M8
M6;&-B#QM4YD;\3\OY5W6N>,X+?X>?V]:L!)=1!+=<])6XQ_P$Y_[YK%^$&@&
MTT>?6YU/GWK;8RW7RP>OXMG\A3HITH2J/?9>I-=JM.-);;OT/2$18XU1%"HH
M`4#H!7CW@J,>(_BMJVK7'SBU:1XP><'=L3\ES7L=>/?#I_[(^).MZ5<';)*9
M%3/<J^1_XZ2:5#X)M;V*Q/\`$II[7_X8]AHHHKE.P*\B\-?\EQUC_MM_[+7K
MM>1>&O\`DN.L?]MO_9:Z</\`#/T.3$_%3]3UQONGZ5Y+\&?^/_7OK'_-Z]:;
M[I^E>2_!G_C_`->^L?\`-Z*7\&I\OS"M_'I_/\CUNBBBN8ZS.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KN]?_Y%S4_^O27_`-`-<)\%?^1;U#_K[_\`
M9%KIA_N\O5')4_WF'HSTRO*?C;_QYZ-_UUE_DM>K5Y3\;?\`CST;_KK+_):,
M)_&B/&_P)?UU/3[/_CQM_P#KFO\`*O)_B>7UGQSH>@!B(CLR/>1\$_D*]8L_
M^/&W_P"N:_RKR?XBL=(^)>A:O)_J,1DG_<<[OT(IX7^+YZDXS^#Y75SUR&&.
MW@C@A0)%&H1%'0`#`%/I`0RAE(((R".]+7*=@5Y'\8?^0UX?^K?^A+7KE>1_
M&'_D->'_`*M_Z$M=.$_C+Y_D<F._@/Y?F>N=J\=\(1CQ'\7-5U2X^=;1I'C#
M<X(.Q/R'\J]B[5X]X`<:/\4=;TN<[6F,JIGN0^X?FN33P_P3MO86)_B4T]K_
M`/#'L-%%%<IV!7D6@_\`)=M4_P"VO_H*UZ[7D6@_\EVU3_MK_P"@K73A_AGZ
M')B?BI^IZ'XMU!]+\):I>1G$D=NVP^C'@'\S7GOPJU'0-$T2ZN+_`%2SM[VY
MFP5EE`8(HXZ^Y)KO?&]H]]X*U>",$N;=F`'?;\W]*\S^'G@KP]XJT.:>]^T?
M;()BCB.7:-I`*G&/K^5:4>3V$N;N9UW/ZQ'E73J>G?\`":^&/^@]I_\`W_6C
M_A-?#'_0>T__`+_K7/\`_"H/"W]V]_[_`/\`]:C_`(5!X6_NWO\`W_\`_K5G
MRX?NS7FQ/9'0?\)KX8_Z#VG_`/?]:\R^*FH:/?7.F:MH^I6T]["Q1_(D#,`/
MF4\>AS^==;_PJ#PM_=O?^_\`_P#6H_X5!X6_NWO_`($?_6K2E*A3ES)LRK0Q
M%6#@TCL]-NOMVEVEWT\^%)/^^@#_`%HI]G:QV-E!:0Y\J"-8TW')P!@45QNU
M]#N5[:D]<IXVUE[2R73K4DW5UP=O4)T_,]/SKIYYX[:WDGE;;'&I9CZ`5Q?A
MJVDUW7[G7KM?W<;XA4]`W;\A^IK:C%:U);+\SGQ$V[4H[R_+J7M(\/KH>EQ[
M@#=2\S-Z'LH]A5VMMT61"K#(-5#IRYXD('N*:JWUD#H\ND=CC-<\.M+F_P!)
M8V]^GS`1G:)/\#_.J&B>,$U:VNM-OP(=22)\#&!+@'.!V8=Q7H/]G#_GJ?\`
MOFO+?B3X5:QU6QURSSLFG6.XVC&U\\-^/0__`%ZZ*52-1\C?H<E>G.G%SBO4
MI^#?^1Z/_7K)_-:]/KS7P/%YWC\INQ_HDAZ>ZUZS_9P_YZG_`+YHQ$TIV8\+
M"3A=%"M2P!%MD]SD4Q-/0'+.6'IC%6P`H``P!TKDG--61VTZ;3NQ:\U\3?\`
M(Q7?U7_T$5Z57+:KX4FU'4YKM;M$60C"E"<8`%;X*I&G4;D[:'+F5&I6I*--
M7=RII/BNTT_2X+62WF9XQ@E<8//UJ[_PF]E_SZW'_CO^-4?^$'N/^?Z+_OV?
M\:/^$'N/^?Z+_OV?\:Z)+!R;;?YG'!YC&*BHZ+T-:Q\5VE_>Q6L=O,K2'`+8
MP./K1XP_Y`#?]=$_G532_"<VGZE#=-=QN(R25"$9XQ6SK>FOJNFFUCD6-BX;
M<PR.*YVZ,*T73>AUQ6(J8:<:J]YWL<EX+_Y#4G_7$_S%=;KPSH-[G_GD:S="
M\-SZ1?M<27$<BF,IA5([C_"MG4;5KW3I[96"M*A4,1P*>(JPE74HO306$HU(
M85PDM=3S[PW_`,C#9_[Q_D:]+KE-+\)W&GZG!=/=1.L9)*A3D\8KJZ6-J1J3
M3B[Z#RVC4I4FJBL[G$^+=&>.=M2@3,3_`.N`_A/K]#5'1/$DVE+Y$J&:USD*
M#\R?3_"O0R`RE6`((P0>]<SJ/@VVN':2RE^SL?X",I_]:M*.)IRA[.ML8XC!
M585?;89Z]BTOB[2&3<9I%/\`=,9S6/JOC%YD,6G(T0[RN.?P%5F\&:F&P)+8
MCUWG_"K]EX)`<-?7.Y1_!$,9_$U:CA*;YKW,Y5,PJKDY;>>W]?(V/#^L_P!K
MV9+QE9HL!R!\I]Q_A6O45O;0VD"PV\:QQKT514M>?4<7)N*LCUZ49Q@E-W85
ME^(M'BU_0+S3)<#SHR$8_P`+CE3^!Q6I14IM.Z+DE)69\RZ?::KJ^H67A-W=
M5CNW'E$?ZICPY_`*3^?K7TI:6L-C9PVEN@2&%!&BCL`,"L2S\)6EGXROO$28
M\RYB5`F/NM_&WX@+^OK70UTXFNJMK;?J<F$P[HIN6_Z=`KRGXF>'[W3=6@\8
MZ.")82IN-HSM*]'QZ8X->K4C*KJ590RL,$$9!%8TJCIRYD;UJ2JPY6<WX2\:
M:=XJLE,4BPWRK^^M6/S`]ROJOO\`G72UYMX@^$MK=71O=!NSIUQG=Y7/E@^J
MD<K^&:RET+XJV8\F'5/.C'`8W"M^KC-;.E2GK"5O)F"K5H:5(7\T>L7=Y;6%
MJ]S=SQP01C+22-@"O'_!5];ZG\8=2OK5B]O.LSQL1C(R.<59C^&?BC7ITE\3
M:Z?+!SL60RL/H.%'ZUO>%_AR_AGQ9)J<-XCV7EM''$02X!QC)Z=JN*I4X27-
M=M&<G6JSB^6R3^9WS?=/TKR7X,_\?^O?6/\`F]>M'D$5QG@7P5<^$KC49;B\
MAN!=[=HC4C;@MUS]:QISBJ4XO=V-ZL).M"2V5_R.THHHK`Z3.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KT/4K5KW2[NT5@K3PO&&/0%@1G]:YWP'X3N
M/".EW-I<74=PTLWF!HU(`&`,<_2MXSBJ,H]=#FG"3KQDMDF=77E/QM_X\]&_
MZZR_R6O5JX[Q]X-N?&$%C';W<5N;9W9C(I.[('I]*,-)0JJ4MAXJ$IT7&.YU
M5G_QXV__`%S7^5<W\0/"Q\4^'FB@`^W6Q\VW)_B..5_$?J!73P1F*WCC)R44
M+GZ"I*SC-PES1-9P4X<LNIYA\/?'L0MT\/:\YMKVV_=123?*'`X"-GHPZ<]?
MK7I_49%<EXK^'ND^*2;A@;2_QC[1$!\W^\/XOY^]<:G@WXB:$/)TG6A-;C[J
MB?`'_`7&!^%=$HTJKYHOE?9G+&5:BN64>9=T>OUXI\4M:T_5/$FE6]C<I.]J
MQ68H<JI++QGN>*N/X.^(NNCR=6UI8;<_>4S\'_@*#!_&IYO@R(OL1L=3'F1M
MNG>9#\YR,;0.@Z^M:48TJ4N:4KOR,Z\JU:'+&%EYGK':O*_B;X>O++4K?Q?I
M`836Y4W&P<KM^Z_N,<'VQ[UZI2,H92K`%2,$$=:Y*51TY<R.RM256'*SF?"/
MC;3O%5DFQTAOU7]]:L>0?5?5?\FNGKS?Q#\);.\NC>Z%='3;G.[R\'R\^HQR
MOX5E#0OBI9#R8-5$T8X#&X5OU<9K9TJ4]82MY,P5:M#2I"_FCU>ZNK>RMGN;
MJ:.&&,9:21@`!]:\?\(7]OJGQGOKZT<O;S+,T;$8R,`9JPGPU\4Z_.DGB;73
MY2G.P2&5A]!PHJIX,TV#1_C%=:=;;_(MTE1-YR<;1U-:TX0A"=I7=C&K4J3J
M0;C97^9[00&!!`((P0:\6N%N_A7XW:YCB>71+XD87^[G.W_>7MZCZU[5534M
M,LM7L9+*_MTGMY!\R,/U'H?>N:C5Y&U)73W.NO1=1)Q=FMANE:O8:U8I>:=<
MI/"XZJ>5/H1U!]C5VO)[WX4ZII=XUWX5UMX">D<CLC#VW+U_$5%_8_Q8<>2=
M2"ITW^?&/U`S6GL*<M8S5O,S6(J1TG!W\CTC7O$>F^&[!KK4;A4X^2('+R'T
M4=ZJ^$/%,7BS1S?1VTMNR.8W1^1G_9;N*XO2OA+/<WHOO%&JO>29R8HW8[O8
MNW./8`?6O3;6UM[&UCMK6%(8(EVI&@P%%145*,;1=WW+I2K3ES25EVZE:YUO
M3+.\%I<WT,4Y&[:[8P.V3T&??K17.:QX1O+[5;B:"6U\F=M^Z=2Q0X4'Y?XO
MNC!R,`GKQ10H4K:R$ZE9-VB3>-KY_(@TJWR9KE@6`],\#\3_`"KH-*L$TS3(
M+1,?NU^8^K=S^=<MHR_VWXMN=2?F*W_U8/Y+^@)^M=K55_<BJ7S?J9X7][.5
M=]=%Z(****YCM"J][96^H6KVUU$)(7QE3['(_6K%%--IW0FDU9F/IOA;1])O
MVO;*S$=RR;#(79CM]!D\5L444.3D[MA&*BK15@HHHI#"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO)/$WQ.UW0O$E_IL=G8O%%
M)B)I%;=MQWPU:TJ4JKM$RK5H45>1ZI>7<%A9S7=U*L4$*%W=CP`*\H^&BRZ]
MXZUKQ(Z%8?F"Y_O.V0/P4?J*IIIOC?XC^6;^XBM=+W`G:P"?@@)+'_>KU?0=
M"LO#FDQ:=8H1&G+,WWG8]6/N:V:C1@XWO)_@<\7+$5(RM:*_%FG1117(=H44
-44`%%%%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
